Diagnosing heart disease in women requires a different approach than in men, because the symptoms, the type of disease, and even the accuracy of standard tests can differ significantly between sexes. Women are more likely to have heart disease that affects smaller blood vessels rather than the major coronary arteries, and their symptoms often don’t match the “classic” heart attack picture most people recognize. These differences mean that some women go through multiple rounds of testing before getting an accurate diagnosis, and understanding what to expect can help you navigate that process.
Why Symptoms Look Different in Women
The textbook heart attack, with crushing chest pain radiating down the left arm, is based largely on how the disease presents in men. Women can absolutely experience chest pain, but they are more likely to have what doctors call an “atypical” presentation: shortness of breath, unusual fatigue, nausea, or pain in the jaw, neck, or back. Some women describe an overwhelming exhaustion in the days or weeks before a cardiac event, or a feeling of indigestion that doesn’t respond to antacids.
These symptoms overlap with many other conditions, which is one reason heart disease in women is sometimes initially attributed to stress, anxiety, or gastrointestinal problems. If you’re experiencing any combination of these symptoms, especially with exertion or emotional stress, it’s worth asking your doctor directly: “What tests do I need to make sure these symptoms are not due to heart disease?”
Standard Tests and Their Limitations
The first steps in evaluating heart disease are typically the same regardless of sex: an electrocardiogram (ECG), blood work, and a clinical history. But the reliability of some of these tools shifts when applied to women.
Exercise Stress Tests
The standard treadmill stress test, which monitors your heart’s electrical activity while you exercise, is less accurate in women. Using the traditional criteria for an abnormal result, the test correctly identifies heart disease about 51% of the time in women compared to 67% in men. That means roughly half of women with coronary artery disease could get a normal-looking result. The test also produces more false positives in women: one large study found that specificity (the ability to correctly rule out disease) was 64% in women versus 73% in men. The exact reason for this gap remains unclear, but it means a stress test alone is often not enough to confirm or rule out heart disease in a woman.
Stress imaging tests, which combine exercise or medication-induced stress with imaging like echocardiography or nuclear scanning, tend to be more reliable than the treadmill ECG alone. If your initial stress test results are unclear, your doctor may recommend one of these as a next step.
Blood Tests and Troponin Levels
When a heart attack is suspected, doctors measure a protein called troponin that leaks into the blood when heart muscle is damaged. Newer high-sensitivity troponin tests now use sex-specific cutoff values: 14 ng/L for women and 22 ng/L for men. Before these separate thresholds were adopted, some women with genuine heart damage were being told their levels were “normal” because they fell below a single cutoff designed around male physiology. If you’re being evaluated in an emergency setting, these sex-specific thresholds improve the chances that a heart attack won’t be missed.
Imaging That Works Better for Women
Because women more often develop disease in smaller blood vessels or have non-obstructive blockages (less than 50% narrowing), imaging tools that can detect subtler problems are particularly valuable.
CT Angiography
Coronary CT angiography (CCTA) creates detailed images of the heart’s arteries without requiring a catheter. It’s especially useful in women because it can visualize the early stages of plaque buildup, even when the arteries aren’t severely blocked. Women with chest pain symptoms are more likely than men to have non-obstructive disease on CCTA, and adding a CT perfusion scan to the standard CCTA improves the ability to detect reduced blood flow in women specifically, an advantage not seen as strongly in men. CCTA also tends to reduce the need for additional testing and associated costs in women with chest pain.
Cardiac MRI
Cardiac MRI (also called CMR) can detect reduced blood flow in the inner layer of the heart muscle even when no significant blockage is visible on an angiogram. This matters because that pattern, ischemia without a major blockage, is a frequent presentation in women. Cardiac MRI is also useful for distinguishing between different causes of heart attack with non-obstructive arteries, a condition sometimes abbreviated as MINOCA. While routine blood flow measurement by MRI isn’t yet standard practice everywhere, it shows good accuracy for identifying small-vessel disease.
PET Scanning
Positron emission tomography (PET) uses small amounts of radioactive tracers to measure blood flow through the heart at rest and under stress. It can calculate an absolute number for how much blood reaches the heart muscle, making it one of the best non-invasive ways to diagnose microvascular disease. PET results correlate well with invasive measurements, which makes it a strong option when small-vessel disease is suspected but a catheter procedure isn’t warranted yet.
Diagnosing Microvascular Disease
Up to half of women who undergo a cardiac catheterization for chest pain have no significant blockages in their major coronary arteries. For many of these women, the problem lies in the tiny blood vessels that branch off the main arteries, a condition called coronary microvascular disease (CMD). Standard angiography can’t see these vessels, so additional testing is needed.
The gold standard for diagnosing CMD is invasive coronary function testing, performed during a catheterization. The doctor administers a series of medications through the catheter to test how well the small vessels dilate. If blood flow doesn’t increase by at least 2.5 times the resting level after one of these medications, that confirms microvascular dysfunction. A separate medication tests whether the vessels spasm inappropriately. This detailed functional testing is recommended by European cardiology guidelines for patients whose symptoms persist despite normal-looking angiograms.
When invasive testing isn’t appropriate, PET, cardiac MRI, or a specialized Doppler ultrasound of one of the heart’s main arteries can estimate similar blood flow measurements non-invasively. These aren’t quite as precise, but they offer a reasonable alternative and can guide treatment decisions.
SCAD: A Heart Attack Cause Unique to Women
Spontaneous coronary artery dissection (SCAD) occurs when the wall of a coronary artery tears, allowing blood to collect between the layers and block flow. It accounts for a significant share of heart attacks in women under 50 and has no connection to traditional risk factors like high cholesterol or smoking. SCAD is most common in women during or shortly after pregnancy, though it can happen at any age.
Coronary angiography is the primary tool for diagnosing SCAD, but the tear can be subtle and doesn’t always look like a typical blockage. In ambiguous cases, doctors may use intravascular ultrasound or optical coherence tomography, both of which thread a tiny imaging probe inside the artery to visualize the layers of the vessel wall directly. These tools can reveal the blood collection between layers and confirm the tear. CT angiography can sometimes detect SCAD as well, though it’s more challenging because the blood collection can be difficult to distinguish from normal surrounding tissue on a CT image.
Calcium Scoring for Early Detection
A coronary artery calcium (CAC) score uses a quick, low-dose CT scan to measure the amount of calcified plaque in your coronary arteries. It’s most useful for women who don’t have symptoms but fall into an intermediate risk category based on traditional factors like age, blood pressure, and cholesterol. In this group, a positive calcium score is associated with a significantly higher rate of future heart events (3.3% versus much lower rates in women with a score of zero). A zero score, on the other hand, is reassuring and may allow you and your doctor to take a less aggressive approach to prevention. The test is quick, involves no contrast dye or injection, and is widely available.
Pregnancy History as a Diagnostic Clue
Complications during pregnancy can serve as an early warning system for heart disease years or decades later. Gestational diabetes and hypertensive disorders of pregnancy (including preeclampsia) are strong independent predictors of future cardiovascular disease. These conditions essentially stress-test the cardiovascular system, and a body that struggles under that load is more likely to develop problems over time.
Current guidelines recommend that women who had gestational diabetes undergo glucose tolerance testing 6 to 12 weeks after delivery and every 1 to 3 years afterward. Women who had preeclampsia or gestational hypertension should have blood pressure checked 7 to 10 days postpartum and receive ongoing cardiovascular risk assessment, though in practice follow-up rates are low. One study found that only about 14% of women attended a blood pressure screening visit within 10 days of delivery. If you had any of these complications, even years ago, bring them up with your doctor. They won’t appear on a standard medical intake form, and most cardiovascular risk calculators still don’t formally include pregnancy history, so it’s information you may need to volunteer.
Getting the Right Workup
The single most important thing you can do is describe your symptoms in detail, including fatigue and shortness of breath, not just chest pain, and push for further evaluation if initial tests come back normal but your symptoms persist. A normal stress ECG in a woman is less reassuring than it would be in a man. Non-obstructive disease and microvascular dysfunction are real, diagnosable conditions that won’t show up on a basic angiogram without additional functional testing. If your symptoms are being attributed to anxiety or stress without cardiac testing to back that up, asking for stress imaging, a calcium score, or a referral to a cardiologist familiar with women’s heart disease is a reasonable next step.